KRISTEN EVANS: Open Payments
NPI 1710266630 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,238 in 87 payments from 19 companies in 2025. Trend: 2023 $2,028 · 2024 $1,690 · 2025 $2,238
Food & beverage: $2,238
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 25 | $534 |
| GENZYME CORPORATION | 16 | $454 |
| GlaxoSmithKline, LLC. | 12 | $231 |
| Grifols USA, LLC | 3 | $167 |
| Regeneron Healthcare Solutions, Inc. | 6 | $151 |
| AstraZeneca Pharmaceuticals LP | 4 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $109 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $76 |
| Genentech USA, Inc. | 3 | $61 |
| LEO Pharma Inc. | 2 | $59 |
Products named: DUPIXENT, Hizentra, NUCALA, Prolastin-C Liquid, TEZSPIRE, Haegarda, TAKHZYRO, NEFFY.
Industry payments across KY — which companies pay providers there.
